The Asia Pacific medical sterile swabs market is expected to reach US$ 1,025.90 million by 2027 from US$ 565.29 million in 2019. The market is estimated to grow at a CAGR of 7.7% from 2020 to 2027.
The growth of the Asia Pacific medical sterile swabs market is attributed to the broader applications of medical sterile swab, growing demand of sterile swab for SARS-CoV-2 detection, and 3D printed sterile swabs. However, challenges associated with sterile swab hinders the growth of the market.
China is the largest- and fastest-growing country for the medical sterile swabs market. Increasing incidences of COVID-19 cases, growing developments for automated swab testing, and rising support from the government to increase PCR testing are among the factors propelling the demand for medical sterile swabs.
Based on product, the Asia Pacific medical sterile swabs market is segmented into cotton tipped swabs, foam tipped swabs, non-woven, and others. In 2019, the cotton tipped swabs segment held the largest share of the market, whereas the non-woven swabs segment is estimated to register the highest CAGR during the forecast period. Based on end user, the Asia Pacific medical sterile swabs market is segmented into hospitals, clinics, diagnostic laboratories, and others. In 2019, the hospitals segment held the largest share of the market, whereas the diagnostic laboratories segment is expected to register a higher CAGR during 2020–2027.
A few major primary and secondary sources referred to in the process of preparing the report on the medical sterile swabs market are the World Health Organization and Clinical Research Network.